Tesla has horrible financials. All companies do until they start commercialization. And ALRTs commercial potential is staggeringly positive. You clearly etiher are out to bash ALR or you know nothing about how valuations are determined for companies in the development stage. Many pharma companies have market caps in the hundreds of millions or billions before they make a first dollar of earnings.
News 
Market Data 
Discover 
AI
